DrugPatentWatch Database Preview
Investigational Drug Information for Adavosertib
Email this page to a colleague
What is the development status for investigational drug Adavosertib?
Adavosertib is an investigational drug.
There have been 28 clinical trials for Adavosertib.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 21st 2014.
The most common disease conditions in clinical trials are Neoplasms, Carcinoma, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), AstraZeneca, and Parexel.
There are thirty-one US patents protecting this investigational drug and three hundred and sixty-six international patents.
Summary for Adavosertib
| US Patents | 31 |
| International Patents | 366 |
| US Patent Applications | 119 |
| WIPO Patent Applications | 134 |
| Japanese Patent Applications | 23 |
| Clinical Trial Progress | Phase 1 (2014-07-21) |
| Vendors | 79 |
Recent Clinical Trials for Adavosertib
| Title | Sponsor | Phase |
|---|---|---|
| Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib | Parexel | Phase 1 |
| Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib | AstraZeneca | Phase 1 |
| A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours | Parexel | Phase 1 |
Clinical Trial Summary for Adavosertib
Top disease conditions for Adavosertib
Top clinical trial sponsors for Adavosertib
US Patents for Adavosertib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Adavosertib | ⤷ Try it Free | Remote loading of sparingly water-soluble drugs into lipid vesicles | ZONEONE PHARMA, INC. (San Francisco, CA) | ⤷ Try it Free |
| Adavosertib | ⤷ Try it Free | Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids | Cantex Pharmaceuticals, Inc. (Weston, FL) | ⤷ Try it Free |
| Adavosertib | ⤷ Try it Free | Silanol based therapeutic payloads | BlinkBio, Inc. (Jupiter, FL) | ⤷ Try it Free |
| Adavosertib | ⤷ Try it Free | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | AstraZeneca AB (Sodertalje, SE) | ⤷ Try it Free |
| Adavosertib | ⤷ Try it Free | Methods and compositions for treatment of cancer and autoimmune disease | THE JACKSON LABORATORY (Bar Harbor, ME) | ⤷ Try it Free |
| Adavosertib | ⤷ Try it Free | Silanol based therapeutic payloads | BlinkBio, Inc. (Jupiter, FL) | ⤷ Try it Free |
| Adavosertib | ⤷ Try it Free | Therapeutic dendrimers | AstraZeneca AB (Sodertalje, SE) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Adavosertib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Adavosertib | Australia | AU2015301234 | 2034-08-04 | ⤷ Try it Free |
| Adavosertib | Canada | CA2962709 | 2034-08-04 | ⤷ Try it Free |
| Adavosertib | China | CN106999419 | 2034-08-04 | ⤷ Try it Free |
| Adavosertib | European Patent Office | EP3177269 | 2034-08-04 | ⤷ Try it Free |
| Adavosertib | World Intellectual Property Organization (WIPO) | WO2016022549 | 2034-08-04 | ⤷ Try it Free |
| Adavosertib | European Patent Office | EP3258941 | 2035-02-17 | ⤷ Try it Free |
| Adavosertib | World Intellectual Property Organization (WIPO) | WO2016133910 | 2035-02-17 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
